berberine has been researched along with Cardiac Failure in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to assess the efficacy and safety of berberine for chronic congestive heart failure (CHF)." | 9.10 | Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Li, YY; Zeng, XH; Zeng, XJ, 2003) |
| "To investigate whether CPU86017, a berberine derivative, attenuates heart failure by blocking calcium influx and exerting its antioxidant activity." | 7.76 | CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity. ( Cheng, YS; Dai, DZ; Dai, Y; Feng, Y; Li, N; Qi, MY, 2010) |
| "To study the effects of total saponins of Panax ginseng combined with berberine on hemodynamics, Plasma brain natriuretic peptide and Ca2+ concentration in cardiac cells of chronic congestive heart failure rats." | 7.75 | [Effects of ginseng total saponins with berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure]. ( Chen, X; Li, G; Li, Y; Liu, H; Luo, F, 2009) |
| "Emerging evidence indicates that leptin may be a potential new target in chronic heart failure (CHF) treatment." | 7.74 | Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017. ( Dai, DZ; Dai, Y; Na, T; Tang, XY, 2007) |
| "It has been reported that berberine is valuable for long-term treatment of ventricular premature beats (VPBs) and leads to a decrease in mortality for patients with congestive heart failure (CHF)." | 7.70 | Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. ( Zeng, X, 1999) |
| "Berberine, an alkaloid of the protoberberine family, has been shown to have strong positive inotropic and peripheral resistance-lowering effects in dogs with and without heart failure." | 7.67 | Cardiovascular effects of berberine in patients with severe congestive heart failure. ( Gallo Júnior, L; Maciel, BC; Marin-Neto, JA; Secches, AL, 1988) |
| "This study was designed to assess the efficacy and safety of berberine for chronic congestive heart failure (CHF)." | 5.10 | Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Li, YY; Zeng, XH; Zeng, XJ, 2003) |
| "To investigate whether CPU86017, a berberine derivative, attenuates heart failure by blocking calcium influx and exerting its antioxidant activity." | 3.76 | CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity. ( Cheng, YS; Dai, DZ; Dai, Y; Feng, Y; Li, N; Qi, MY, 2010) |
| "To study the effects of total saponins of Panax ginseng combined with berberine on hemodynamics, Plasma brain natriuretic peptide and Ca2+ concentration in cardiac cells of chronic congestive heart failure rats." | 3.75 | [Effects of ginseng total saponins with berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure]. ( Chen, X; Li, G; Li, Y; Liu, H; Luo, F, 2009) |
| "Emerging evidence indicates that leptin may be a potential new target in chronic heart failure (CHF) treatment." | 3.74 | Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017. ( Dai, DZ; Dai, Y; Na, T; Tang, XY, 2007) |
| "It has been reported that berberine is valuable for long-term treatment of ventricular premature beats (VPBs) and leads to a decrease in mortality for patients with congestive heart failure (CHF)." | 3.70 | Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. ( Zeng, X, 1999) |
| "Berberine, an alkaloid of the protoberberine family, has been shown to have strong positive inotropic and peripheral resistance-lowering effects in dogs with and without heart failure." | 3.67 | Cardiovascular effects of berberine in patients with severe congestive heart failure. ( Gallo Júnior, L; Maciel, BC; Marin-Neto, JA; Secches, AL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, YW | 1 |
| Li, XD | 1 |
| Sun, MJ | 1 |
| Liu, ZP | 1 |
| Liu, SW | 1 |
| Li, Y | 1 |
| Chen, X | 1 |
| Liu, H | 1 |
| Luo, F | 1 |
| Li, G | 1 |
| Qi, MY | 1 |
| Feng, Y | 1 |
| Dai, DZ | 2 |
| Li, N | 1 |
| Cheng, YS | 1 |
| Dai, Y | 2 |
| Zeng, XH | 1 |
| Zeng, XJ | 1 |
| Li, YY | 1 |
| Na, T | 1 |
| Tang, XY | 1 |
| Yang, SY | 1 |
| Zeng, X | 2 |
| Marin-Neto, JA | 1 |
| Maciel, BC | 1 |
| Secches, AL | 1 |
| Gallo Júnior, L | 1 |
1 review available for berberine and Cardiac Failure
| Article | Year |
|---|---|
[Study on inotropic action of berberine].
Topics: Animals; Berberine; Cyclic AMP; Heart Failure; Humans; Myocardial Contraction; Stimulation, Chemical | 1994 |
1 trial available for berberine and Cardiac Failure
| Article | Year |
|---|---|
Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Aged; Aged, 80 and over; Berberine; Cardiomyopathy, Dilated; Double-Blind Method; Exercise Test; Fem | 2003 |
6 other studies available for berberine and Cardiac Failure
| Article | Year |
|---|---|
[Protective effects of berberine against exhaustion exercise induced myocardial injury in rats].
Topics: Animals; Berberine; Heart Failure; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley | 2019 |
[Effects of ginseng total saponins with berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure].
Topics: Animals; Berberine; Calcium; Disease Models, Animal; Heart Failure; Hemodynamics; Male; Natriuretic | 2009 |
CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity.
Topics: Animals; Antioxidants; Base Sequence; Berberine; Calcium; Calcium-Binding Proteins; DNA Primers; Dow | 2010 |
Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017.
Topics: Alkyl and Aryl Transferases; Animals; Anti-Arrhythmia Agents; Antioxidants; Aspartic Acid Endopeptid | 2007 |
Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC.
Topics: Aged; Anticoagulants; Berberine; Blood Pressure; Chromatography, High Pressure Liquid; Chronic Disea | 1999 |
Cardiovascular effects of berberine in patients with severe congestive heart failure.
Topics: Adult; Aged; Berberine; Berberine Alkaloids; Echocardiography; Electrocardiography; Female; Heart Fa | 1988 |